BIOMUNEX PHARMACEUTICALS

City:

Paris

Country:

France

Published Applications:

Last publication date:

2023-05-11

Patent Grants:

Last grant date:

2026-01-20

Top Inventors for applications by BIOMUNEX PHARMACEUTICALS

These are the the leading inventors for applications assigned to BIOMUNEX PHARMACEUTICALS:

Olivier Leger 5 Saint-Sixt, France
EUGENE ZHUKOVSKY 4 BETHEL, CT United States
RICHARD J. MORSE 3 BETHEL, CT United States
ANDRE PELEGRIN 1 PARIS, France

EUGENE ZHUKOVSKY 1 PARIS, France
PIERRE-EMMANUEL GERARD 1 PARIS, France
CHRISTEL LARBOURET 1 PARIS, France

Recent patent applications by BIOMUNEX PHARMACEUTICALS

BIOMUNEX PHARMACEUTICALS based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-05-11 ✅ Patent 12,528,877 granted on 2026-01-20

US20230146591A1

Chemistry; metallurgy

BINDING MOLECULES TO CD38 AND PD-L1

#2 | 2020-09-24 ✅ Patent 11,560,437 granted on 2023-01-24

US20200299413A1

Chemistry; metallurgy

Stable multispecific antibodies

#3 | 2020-01-09 ✅ Patent 11,505,616 granted on 2022-11-22

US20200010559A1

Chemistry; metallurgy

Binding molecules to CD38 and PD-L1

#4 | 2019-10-31 ✅ Patent 11,958,913 granted on 2024-04-16

US20190330377A1

Chemistry; metallurgy

Polypeptide linker for preparing multispecific antibodies

#5 | 2019-05-23 ✅ Patent 12,054,550 granted on 2024-08-06

US20190153104A1

Chemistry; metallurgy

Bispecific antibodies targeting EGFR and HER2

Also check out BIOMUNEX PHARMACEUTICALS's (Paris, France) applicant profile with 7 patent applications submitted.

AssigneeID:

355972 ⎘